VT8-30074-89951 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-30
Dose 1 — Pfizer-BioNTech
2021-08-12
Registered in v-safe
2021-08-12
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-08-20
Dose 2 — Pfizer-BioNTech
2021-08-22
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Heart rate increased, Heart rate irregular — Feeling: Fair · Site: Pain · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Irregular heartbeat and harder time breathing day after 2nd dose; elevated heart rate

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-22
Report sent to call center — days 1–6 daily, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-24
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-30	Pfizer-BioNTech	No
2	2021-08-20	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-08-22	Unsuccessful

Free text

Release 9 — days 1–6 daily, dose 2

2021-08-22

Systemic reaction (other): Irregular heartbeat and harder time breathing day after 2nd dose; elevated heart rate

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Dyspnoea	✓	·	✓
SRO	Heart rate increased	✓	·	✓
SRO	Heart rate irregular	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release